search
Back to results

Acupuncture in Treating Hot Flashes in Women With Breast Cancer

Primary Purpose

Breast Cancer, Hot Flashes

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
acupuncture therapy
hot flashes attenuation
management of therapy complications
Sponsored by
Memorial Sloan Kettering Cancer Center
About
Eligibility
Locations
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Breast Cancer focused on measuring breast cancer in situ, stage I breast cancer, stage II breast cancer, stage IIIA breast cancer, stage IIIB breast cancer, stage IV breast cancer, recurrent breast cancer, stage IIIC breast cancer, hot flashes

Eligibility Criteria

undefined - undefined (Child, Adult, Older Adult)FemaleDoes not accept healthy volunteers

DISEASE CHARACTERISTICS: Diagnosis of breast cancer (including in situ disease) Must be receiving treatment for breast cancer at Memorial Sloan Kettering Cancer Center (MSKCC) or its regional site (Commack) Has an average of 3 or more hot flashes a day during 1 week of baseline diary recording Hormone receptor status not specified PATIENT CHARACTERISTICS: Female Pre- or postmenopausal Karnofsky performance status 70-100% Ambulatory No skin infection PRIOR CONCURRENT THERAPY: More than 3 weeks since prior and no concurrent treatment with any of the following during the 6 week evaluation period of the trial: Surgery Initiation of a new chemotherapy regimen Initiation of immunotherapy Initiation of radiotherapy Initiation or cessation of hormonal therapy More than 6 weeks since prior acupuncture treatment (6 months for acupuncture specifically for the treatment of hot flashes) No concurrent pharmacological treatment for hot flashes unless dose has been stable for 4 weeks No concurrent selective serotonin reuptake inhibitors (SSRIs) unless dose has been stable for 4 weeks

Sites / Locations

  • Memorial Sloan-Kettering Cancer Center

Outcomes

Primary Outcome Measures

Frequency and severity of hot flashes, as measured by a hot flash diary

Secondary Outcome Measures

Full Information

First Posted
April 27, 2004
Last Updated
December 11, 2012
Sponsor
Memorial Sloan Kettering Cancer Center
Collaborators
National Cancer Institute (NCI)
search

1. Study Identification

Unique Protocol Identification Number
NCT00081965
Brief Title
Acupuncture in Treating Hot Flashes in Women With Breast Cancer
Official Title
Acupuncture for the Treatment of Hot Flashes in Breast Cancer Patients: A Randomized Controlled Trial
Study Type
Interventional

2. Study Status

Record Verification Date
December 2012
Overall Recruitment Status
Completed
Study Start Date
undefined (undefined)
Primary Completion Date
May 2007 (Actual)
Study Completion Date
May 2007 (Actual)

3. Sponsor/Collaborators

Name of the Sponsor
Memorial Sloan Kettering Cancer Center
Collaborators
National Cancer Institute (NCI)

4. Oversight

5. Study Description

Brief Summary
RATIONALE: Acupuncture may help relieve hot flashes in women with breast cancer. It is not yet known whether acupuncture is more effective than a placebo in treating hot flashes in women with breast cancer PURPOSE: This randomized clinical trial is studying acupuncture to see how well it works compared to a placebo in treating hot flashes in women with breast cancer.
Detailed Description
OBJECTIVES: Primary Determine whether acupuncture, compared to placebo, reduces the incidence of hot flashes in women with breast cancer. Secondary Determine the long-term effects of acupuncture on hot flashes. OUTLINE: This a randomized, placebo-controlled, multicenter study. Patients are stratified according to concurrent treatment with selective estrogen receptor modulators, gonadotropin-releasing hormone analogs, or aromatase inhibitors (yes vs no), concurrent use of hot flash medication or selective serotonin reuptake inhibitors (SSRIs) (yes vs no), baseline hot flash frequency (> 7 per day), and menopausal status at diagnosis (premenopausal vs postmenopausal). Patients are randomized to 1 of 2 treatment arms. Arm I (treatment): Patients receive 8 acupuncture treatments over 4 weeks. Arm II (control): Patients receive 8 placebo acupuncture treatments over 4 weeks. Beginning at week 7, patients are offered 8 true acupuncture treatments over 4 weeks. Patients in both arms complete a "hot flash" diary for 1 week before treatment and then periodically during and after treatment. After completion of study treatment, patients are followed periodically. PROJECTED ACCRUAL: A total of 80 patients will be accrued for this study.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Breast Cancer, Hot Flashes
Keywords
breast cancer in situ, stage I breast cancer, stage II breast cancer, stage IIIA breast cancer, stage IIIB breast cancer, stage IV breast cancer, recurrent breast cancer, stage IIIC breast cancer, hot flashes

7. Study Design

Primary Purpose
Supportive Care
Study Phase
Not Applicable
Allocation
Randomized
Enrollment
80 (Anticipated)

8. Arms, Groups, and Interventions

Intervention Type
Procedure
Intervention Name(s)
acupuncture therapy
Intervention Type
Procedure
Intervention Name(s)
hot flashes attenuation
Intervention Type
Procedure
Intervention Name(s)
management of therapy complications
Primary Outcome Measure Information:
Title
Frequency and severity of hot flashes, as measured by a hot flash diary

10. Eligibility

Sex
Female
Accepts Healthy Volunteers
No
Eligibility Criteria
DISEASE CHARACTERISTICS: Diagnosis of breast cancer (including in situ disease) Must be receiving treatment for breast cancer at Memorial Sloan Kettering Cancer Center (MSKCC) or its regional site (Commack) Has an average of 3 or more hot flashes a day during 1 week of baseline diary recording Hormone receptor status not specified PATIENT CHARACTERISTICS: Female Pre- or postmenopausal Karnofsky performance status 70-100% Ambulatory No skin infection PRIOR CONCURRENT THERAPY: More than 3 weeks since prior and no concurrent treatment with any of the following during the 6 week evaluation period of the trial: Surgery Initiation of a new chemotherapy regimen Initiation of immunotherapy Initiation of radiotherapy Initiation or cessation of hormonal therapy More than 6 weeks since prior acupuncture treatment (6 months for acupuncture specifically for the treatment of hot flashes) No concurrent pharmacological treatment for hot flashes unless dose has been stable for 4 weeks No concurrent selective serotonin reuptake inhibitors (SSRIs) unless dose has been stable for 4 weeks
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Barrie R. Cassileth, PhD
Organizational Affiliation
Memorial Sloan Kettering Cancer Center
Official's Role
Principal Investigator
Facility Information:
Facility Name
Memorial Sloan-Kettering Cancer Center
City
New York
State/Province
New York
ZIP/Postal Code
10021
Country
United States

12. IPD Sharing Statement

Citations:
PubMed Identifier
18065731
Citation
Deng G, Vickers A, Yeung S, D'Andrea GM, Xiao H, Heerdt AS, Sugarman S, Troso-Sandoval T, Seidman AD, Hudis CA, Cassileth B. Randomized, controlled trial of acupuncture for the treatment of hot flashes in breast cancer patients. J Clin Oncol. 2007 Dec 10;25(35):5584-90. doi: 10.1200/JCO.2007.12.0774. Erratum In: J Clin Oncol. 2008 Mar 20;26(9):1572. D'Andrea, Gabriella M [added]; Xiao, Han [added]; Heerdt Alexandra S [added]; Sugarman, Stephen [added]; Troso-Sandoval, Tiffany [added]; Seidman, Andrew D [added]; Hudis, Clifford A [added].
Results Reference
result

Learn more about this trial

Acupuncture in Treating Hot Flashes in Women With Breast Cancer

We'll reach out to this number within 24 hrs